People who have a kidney, liver or heart transplant are at high risk of developing diabetes. This can lead to cardiovascular disease and the rejection of the transplant. Factors such as age, weight and family history can increase the risk of new-onset diabetes after transplantation. Importantly, drugs that suppress the immune system and prevent transplant rejection also play a key role. In December 2003, an international panel of experts in transplantation and diabetes met to update the existing guidelines for the management of new-onset diabetes after transplantation. Jaime A Davidson acted as Chairman of that panel; here he provides an overview of newonset diabetes after transplantation and summarizes the recommendations.
transplant, transplantation, kidney, liver, immune system, new-onset diabetes, guidelines,